While both tumor types grew at a very similar rate in the absence of treatment (control group), or under letrozole or tamoxifen treatment, ER+ tumors grew significantly slower than ERαKD tumors after 14 days of fulvestrant treatment (p < 0.05). Here, ESR1 is linked to neoplasm.